Torben Plesner
Impact in
- Hematology top 0.1%
- Multiple Myeloma Research and Treatments
- Oncology top 1%
- Peptidase Inhibition and Analysis
- Bone health and treatments
Papers in
- Hematology 108
- Multiple Myeloma Research and Treatments 91
- Oncology 69
- Peptidase Inhibition and Analysis 28
- Bone health and treatments 14
- Co-authors
- Henk M. Lokhorst (23 shared papers)Niels W.C.J. van de Donk (19 shared papers)Tahamtan Ahmadi (17 shared papers)A. Kate Sasser (13 shared papers)Jakub Krejcik (11 shared papers)Jean‐Marie Delaissé (13 shared papers)Michael Ploug (5 shared papers)Thomas Levin Andersen (8 shared papers)
- Journals
- Blood (43 papers)Journal of Clinical Oncology (12 papers)Scandinavian Journal of Immunology (11 papers)British Journal of Haematology (9 papers)Haematologica (3 papers)
- Partner nations
- DenmarkUnited StatesNetherlands
In The Last Decade
Torben Plesner
164 papers receiving 5.6k citations
Torben Plesner's Hit Papers
Peers
Comparison fields: 5 of 112
- Hematology 3.1k
- Oncology 2.1k
- Genetics 780
- Immunology 1.3k
- Physiology 228
Countries citing papers authored by Torben Plesner
This map shows the geographic impact of Torben Plesner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Torben Plesner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Torben Plesner more than expected).
Fields of papers citing papers by Torben Plesner
This network shows the impact of papers produced by Torben Plesner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Torben Plesner. The network helps show where Torben Plesner may publish in the future.
Co-authors
The 25 scholars most cited alongside Torben Plesner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 170 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Daratumumab depletes CD38+ immune regulatory cells, promotes T-cell expansion, and skews T-cell repertoire in multiple myeloma Hit paper breakdown → | 2016 | 680 |
| 2 | Clinical efficacy of daratumumab monotherapy in patients with heavily pretreated relapsed or refractory multiple myeloma Hit paper breakdown → | 2016 | 313 |
| 3 | 2008 | 258 | |
| 4 | 2002 | 199 | |
| 5 | 2005 | 170 | |
| 6 | 2017 | 168 | |
| 7 | 2015 | 166 | |
| 8 | 1997 | 143 | |
| 9 | 2013 | 134 | |
| 10 | 1994 | 133 | |
| 11 | 2013 | 126 | |
| 12 | 2017 | 124 | |
| 13 | 1992 | 123 | |
| 14 | 2014 | 117 | |
| 15 | 2005 | 108 | |
| 16 | 2018 | 97 | |
| 17 | 1994 | 94 | |
| 18 | 2006 | 92 | |
| 19 | 1995 | 91 | |
| 20 | 2016 | 89 |
About Torben Plesner
Torben Plesner is a scholar working on Hematology, Oncology, Molecular Biology, Immunology and Genetics, having authored 170 papers that have together received 5.9k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (91 papers), Monoclonal and Polyclonal Antibodies Research (30 papers), Chronic Lymphocytic Leukemia Research (30 papers), Peptidase Inhibition and Analysis (28 papers), Protein Degradation and Inhibitors (17 papers), T-cell and B-cell Immunology (16 papers), Bone health and treatments (14 papers) and Immune Cell Function and Interaction (14 papers). The work is most often cited by research in Hematology (3.1k citations), Oncology (2.1k citations), Genetics (780 citations), Immunology (1.3k citations) and Physiology (228 citations). Torben Plesner has collaborated with scholars based in Denmark, United States and Netherlands. Frequent co-authors include Henk M. Lokhorst, Niels W.C.J. van de Donk, Tahamtan Ahmadi, A. Kate Sasser, Jakub Krejcik, Jean‐Marie Delaissé, Michael Ploug, Thomas Levin Andersen, Paul G. Richardson and Keld Danø. Their work appears in journals such as Blood, Journal of Clinical Oncology, Scandinavian Journal of Immunology, British Journal of Haematology and Haematologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.